Laboratory investigations - autoantibody markers of autoimmune neurological disease
Overview
- Antinuclear antibody (ANA) testing screens for a broad range of autoantibodies targeting nuclear antigens - the standard first-line screen when systemic autoimmune disease is suspected
- ANA positivity is common in the general population (up to ~15-20% at low titre) and rises with age - a positive result alone is not diagnostic of anything
5 more sections, plus exam facts
Premium unlocks every note across every specialty, and the full exam fact library behind it.
Get premium access